Targeted Conditioning of Iomab-B ( 131 I-anti-CD45) Prior to Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care in Relapsed or Refractory Acute Myeloid Leukemia (AML): Preliminary Feasibility and Safety Results from the Prospective, Randomized Phase 3 Sierra Trial

2018
    • Correction
    • Source
    • Cite
    • Save
    0
    References
    7
    Citations
    NaN
    KQI
    []
    Baidu
    map